Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
November 12 2021 - 6:32AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2021
Commission File Number: 001-39633
Abcam plc
(Translation
of registrants name into English)
Discovery
Drive
Cambridge Biomedical Campus
Cambridge, CB2 0AX
United Kingdom
(Address
of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On November 10, 2021, Abcam plc (the Company) issued a regulatory news service announcement (the
Announcement), as required by the laws and regulations of the United Kingdom, announcing that the Company submitted an application for the admission to trading on AIM of 1,784,189 ordinary shares of 0.2 pence each in the Company
(the New Ordinary Shares). These New Ordinary Shares have been issued to satisfy share options vesting under AbShare, the Companys all employee share scheme launched in 2018 and rank pari passu with the existing shares of
the Company. Admission to trading on AIM of the New Ordinary Shares is anticipated to occur on 12 November. The Announcement also covered the exercise of options for the receipt of ordinary shares by the Companys Chief Executive Officer and by
its General Counsel. The Announcement is furnished herewith as Exhibit 99.1 to this Report on Form 6-K.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
ABCAM PLC
|
|
|
|
|
Date: November 12, 2021
|
|
|
|
By:
|
|
/s/ Alan Hirzel
|
|
|
|
|
|
|
Name:
|
|
Alan Hirzel
|
|
|
|
|
|
|
Title:
|
|
Chief Executive Officer
|
Abcam (NASDAQ:ABCM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Abcam (NASDAQ:ABCM)
Historical Stock Chart
From Apr 2023 to Apr 2024